kinetic sidebar2

Technology

Cambryn is a specialized plasma protein fractionator. The Company owns a proprietary technology platform, which represents the next generation in plasma protein extraction. This unique plasma separation is based on a “salting-out” process which provides the first protein precipitation. This precipitation provides two specific protein extraction cascades, one that yields our Fibrinogen Concentrate and supernatant that yields our IgG, A1 and other future proteins including factor XI, which has received orphan drug designation from the US FDA. Cambryn intends to be in a position to launch many plasma based therapeutics in 2019/2020.

In addition to its own product development focused on plasma based therapeutic drugs, Cambryn has provided and continues to provide development services as a CDMO (Contract Development Manufacturing Organization). Cambryn provides development services as a CDMO though a highly versatile process which can be adapted to extract a variety of specialized plasma enzymes and protein components.

What is Fibrinogen? Fibrinogen plays a very important role in blood clotting. Fibrinogen is a protein produced by the liver. When there is tissue damage (trauma), e.g., cutting your finger, the Fibrinogen acts to form the scaffolding, known as a “fibrin clot”. Without Fibrinogen, we would likely bleed to death from even minor injury.

What is immunoglobulin G (IgG)? IgG is the most abundant type of antibody, is found in all body fluids and protects against bacterial and viral infections. Immunoglobulin M (IgM), which is found mainly in the blood and lymph fluid, is the first antibody to be made by the body to fight a new infection.

What is A1PI (Alpha-1 Antitrypsin)? A1PI is a protease inhibitor Although, there are several indication for A1PI it is primarily used to treat patients with COPD (Chronic Obstructive Pulmonary Disease). 

Read About Our Latest News

news2

Read About Our Products

filter

Cambryn Biologics LLC

Cambryn Biologics LLC is a Delaware corporation having its principal facility and offices in Sarasota, Florida. Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies.

logo small

State-of-the-Art Manufacturing Facility

Our facility consists of 50,000 square feet, located adjacent to the Sarasota/Bradenton International Airport, Sarasota, Florida, USA. Cambryn Biologics operates a state-of-the-art manufacturing facility.

Contact Details

Address: 600 Tallevast Rd.
Suite 201 Sarasota, FL 34243

Phone: (941) 355-7400

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.